NxStage Medical

Rank: 88

2016 Rank97 Employees3,400 Revenue:$366,378,000 R&D Spend:$31,032,000 Fiscal year ending:12-31-16 Click here to see all 100

Jeff Burbank, Founder and CEO, accepted on behalf of NxStage Medical, Inc. the Home Dialyzors United Trailblazer Award, for innovation and advancement of home dialysis and for developing the first commercially available portable home hemodialysis machine.

NxStage Kidney Care Opens New Dialysis Centers in Baltimore, Maryland. National Donate Life Month: NxStage Teams Up with Organ Donation Nonprofit MatchingDonors.com. NxStage and Spindial Announce Partnership with Niguarda-Ca' Granda Hospital in Milan. NxStage System One Now in Eight of Top 10 U.S. Nephrology Hospitals. NxStage Launches New Spanish-Language Resources for Hispanic Patients. NxStage Kicks Off 10th Anniversary of Innovation Milestone with Summer-Long Celebration of Patient Life Achievements. NxStage Establishes New Scientific Advisory Board to Build Clinical Evidence and Drive Adoption of Home Hemodialysis Therapy. NxStage Kidney Care Opens Dialysis Center in Parkland, Florida. NxStage Kidney Care Brings Flexible Therapy Options To Greater Boston Area. NxStage Establishes Annual Zenith Award To Recognize Excellence in Acute Renal Care.

Key Personnel: Jeff Burbank, CEO; Matthew Towse, CFO; Joseph Turk Jr, president; Lisa Curtis, SVP, international; Todd Snell, SVP of QA, regulatory & clinical affairs; Tom Shea, SVP & COO; Winifred Swan, SVP, general counsel; Jeffrey Rains, SVP, sales and marketing; Darren Scandone, SVP, HR; Mark Wyeth, SVP, product development;

350 MERRIMACK STREET
Lawrence, Massachusetts
1843
USA

VISIT THEIR WEBSITE